Neurocrine Biosciences (NBIX) Net Margin (2009 - 2026)
Neurocrine Biosciences (NBIX) reported Net Margin of 18.39% for Q3 2026, down 7.96 percentage points from 26.36% a year earlier but up 3.34 percentage points from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Net Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Neurocrine Biosciences' Net Margin came in at 18.98%, up 3.02 percentage points year-over-year; for FY2025, it came in at 16.73%, up 2.24 percentage points from FY2024.
- Net Margin has increased for four consecutive years, though with a five-year change of -22.21 percentage points (FY2020 to FY2025).
- By year, Net Margin came in at 14.49% in FY2024 (+1.26 pp), 13.23% in FY2023 (+2.85 pp), 10.38% in FY2022 (+2.47 pp) and 7.90% in FY2021 (-31.04 pp).
- Five-year quarterly Net Margin spans a low of -18.22% in Q1 2023 and a high of 28.67% in Q4 2023.
- Year over year, Net Margin gained in four of the last eight quarters, with an average year-over-year change of +0.98 percentage points.
- The high point for year-over-year Net Margin in five years was Q1 2024 (a gain of 26.64 percentage points); the low point was Q4 2021 (a drop of 142.68 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 15.06% (Q2 2026), 24.30% (Q1 2026) and 19.08% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 19.55% |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | 18.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 18.39% |
| Jun 30, 2026 | 15.06% |
| Mar 31, 2026 | 24.30% |
| Dec 31, 2025 | 19.08% |
| Sep 30, 2025 | 26.36% |
| Jun 30, 2025 | 15.64% |
| Mar 31, 2025 | 1.38% |
| Dec 31, 2024 | 16.43% |
| Sep 30, 2024 | 20.86% |
| Jun 30, 2024 | 11.01% |
| Mar 31, 2024 | 8.42% |
| Dec 31, 2023 | 28.67% |
| Sep 30, 2023 | 16.66% |
| Jun 30, 2023 | 21.10% |
| Mar 31, 2023 | -18.22% |
| Dec 31, 2022 | 21.60% |
| Sep 30, 2022 | 17.66% |
| Jun 30, 2022 | -4.47% |
| Mar 31, 2022 | 4.48% |
| Dec 31, 2021 | -2.34% |
API Access
Neurocrine Biosciences Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();